<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-13T13:44:49+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年，这些中国生物科技公司在科创板上市</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/BJJsMPg-TZRO4zxQ-U1-Jg</id>
    <link href="https://mp.weixin.qq.com/s/BJJsMPg-TZRO4zxQ-U1-Jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>发展的元年：2021年度新锐公司榜，细胞/基因治疗占15席</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/mCKXvwfM_KqupmVSr7ifFg</id>
    <link href="https://mp.weixin.qq.com/s/mCKXvwfM_KqupmVSr7ifFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恢复期患者血浆无助新冠重症患者康复</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/MnyVKqmPrK70qxwvRbj6eg</id>
    <link href="https://mp.weixin.qq.com/s/MnyVKqmPrK70qxwvRbj6eg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不再预留第二针，美当局调整疫苗免疫策略</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/zfCIO7qpxdSV6SYl5uvpWQ</id>
    <link href="https://mp.weixin.qq.com/s/zfCIO7qpxdSV6SYl5uvpWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再生元新冠中和抗体获超26亿美元大订单，2020年销售1.84亿美元</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/ZeuowcSg6c21q6LiNCbAXw</id>
    <link href="https://mp.weixin.qq.com/s/ZeuowcSg6c21q6LiNCbAXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>股价大涨超17%，22亿美元！百济PD-1授权诺华创License out新纪录</title>
    <updated>2021-01-12T12:35:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/HWro2YXzELCevAOQQR5Lwg</id>
    <link href="https://mp.weixin.qq.com/s/HWro2YXzELCevAOQQR5Lwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“死亡之谷”的回音？礼来阿尔茨海默药物Donanemab二期临床成功</title>
    <updated>2021-01-12T12:35:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/JZqONDxGhnzFU4Y0phbLwg</id>
    <link href="https://mp.weixin.qq.com/s/JZqONDxGhnzFU4Y0phbLwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤相关中性粒细胞</title>
    <updated>2021-01-12T12:35:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/J6tFgTq1lc2ySWVmKR1uBw</id>
    <link href="https://mp.weixin.qq.com/s/J6tFgTq1lc2ySWVmKR1uBw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR技术的传承：CAR-NK、CAR-NKT、CAR-M、CAR-Treg</title>
    <updated>2021-01-11T12:03:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/N2_q_qoxDiFRxgPczKNzXQ</id>
    <link href="https://mp.weixin.qq.com/s/N2_q_qoxDiFRxgPczKNzXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>继英国和南非变异新冠病毒后，日本又发现一变种</title>
    <updated>2021-01-11T12:03:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/zJbNYO92Sbc-1V6g3NDo6A</id>
    <link href="https://mp.weixin.qq.com/s/zJbNYO92Sbc-1V6g3NDo6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>送抗肿瘤药一朵小红花---近期肿瘤药物研发利好政策汇总</title>
    <updated>2021-01-11T12:03:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/DsE2TLFlpas6qdVFT0Pmmw</id>
    <link href="https://mp.weixin.qq.com/s/DsE2TLFlpas6qdVFT0Pmmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>线下研讨会(上海) | 抗体药物研发与工艺开发</title>
    <updated>2021-01-11T12:03:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/lj916AsZlE0_eLFMouulmA</id>
    <link href="https://mp.weixin.qq.com/s/lj916AsZlE0_eLFMouulmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯43|纵览全球药物靶点动态</title>
    <updated>2021-01-10T10:47:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/jequ35oeCoMhsniLAjyi6w</id>
    <link href="https://mp.weixin.qq.com/s/jequ35oeCoMhsniLAjyi6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因疗法的3大困扰</title>
    <updated>2021-01-10T10:47:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/MSgGWnCN7NQaqbtLsdzu3Q</id>
    <link href="https://mp.weixin.qq.com/s/MSgGWnCN7NQaqbtLsdzu3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>双特异性抗体组合的高通量功能筛选</title>
    <updated>2021-01-08T21:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/cWsg63eBsZXIr9_RPD4DEA</id>
    <link href="https://mp.weixin.qq.com/s/cWsg63eBsZXIr9_RPD4DEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疑云笼罩，Sarepta公布DMD基因疗法Ⅱ期临床结果</title>
    <updated>2021-01-08T21:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/eFb0nykdt3BOoOcmmKjG-A</id>
    <link href="https://mp.weixin.qq.com/s/eFb0nykdt3BOoOcmmKjG-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>COVID-19对2020年生物制药并购的影响</title>
    <updated>2021-01-08T12:37:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/mU1hKZ2ahf_BSgqx9m3Oiw</id>
    <link href="https://mp.weixin.qq.com/s/mU1hKZ2ahf_BSgqx9m3Oiw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞DMD基因疗法III期临床完成首次给药</title>
    <updated>2021-01-08T12:37:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/m6IO_63VUbwy7oiZ63Zoag</id>
    <link href="https://mp.weixin.qq.com/s/m6IO_63VUbwy7oiZ63Zoag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞新冠疫苗可能对英国及南非变异新冠疫苗有效！</title>
    <updated>2021-01-08T12:37:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/893F54kQ1Nw9Idi5NvqbPA</id>
    <link href="https://mp.weixin.qq.com/s/893F54kQ1Nw9Idi5NvqbPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：国内外生物制药行业女性高管</title>
    <updated>2021-01-07T13:29:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/bSQELowFexWQnwJqUZV48Q</id>
    <link href="https://mp.weixin.qq.com/s/bSQELowFexWQnwJqUZV48Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>